Omkar Pravin Herlekar

Omkar Pravin Herlekar

Chief Executive Officer at LASA SUPERGENERICS LIMITED
45 year
Process Industries
Consumer Services
Health Technology

Profile

Omkar Pravin Herlekar is currently Chairman & Managing Director at Lasa Supergenerics Ltd. since 2016.
Holds Director positions at Rishichem Research Pvt Ltd., Desh Chemicals Pvt Ltd., Svaks Biotech India Pvt Ltd., Delicare Lifesciences Pvt Ltd. since 2013, Urdhwa Chemicals Co. Pvt Ltd. since 2011, and Harishree Aromatics & Chemicals Pvt Ltd. since 2015.
Formerly Director at Lasa Laboratory Pvt Ltd. from 2012 to 2021, Non-Independent Non-Executive Director at Amarnath Securities Ltd. from 2022 to 2025, and Executive Director at Omkar Speciality Chemicals Ltd. from 2007 to 2017.
Education includes undergraduate and graduate degrees from the University of Mumbai and a doctorate from the Institute of Chemical Technology.

Omkar Pravin Herlekar active positions

CompaniesPositionStart
LASA SUPERGENERICS LIMITED Chief Executive Officer 2016-03-10
Director/Board Member 2011-06-16
Svaks Biotech India Pvt Ltd.
Director/Board Member 2013-09-29
Director/Board Member 2013-09-29
Director/Board Member 2013-08-06
Director/Board Member 2013-08-06
Director/Board Member 2015-09-29

Former positions of Omkar Pravin Herlekar

CompaniesPositionEnd
AMARNATH SECURITIES LIMITED Director/Board Member 2025-01-16
Director/Board Member 2021-11-07
░░░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Omkar Pravin Herlekar's experience

Training of Omkar Pravin Herlekar

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

33

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Consumer Services

Process Industries

Health Technology

Process Industries

Process Industries

Commercial Services

Consumer Services

Finance

Svaks Biotech India Pvt Ltd.

Commercial Services

Process Industries

Health Technology

  1. Stock Market
  2. Insiders
  3. Omkar Pravin Herlekar